|
End-of-day quote
Lima
2026-09-17
|
5-day change | 1st Jan Change | ||
| 64.10 USD | 0.00% |
|
-4.07% | +19.01% |
| 09-18 | Anthropic quietly sets up biology lab as it ramps AI drug program | RE |
| 09-18 | US weighs allowing most pharma licensing deals with China, sources say | RE |
| Market Cap | 129B 112B 106B 96.31B 180B 12,360B 181B 1,270B 490B 6,284B 484B 473B 20,220B | P/E 2026 * |
11.2x | P/E 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 158B 137B 130B 118B 221B 15,118B 222B 1,554B 600B 7,686B 592B 579B 24,731B | EV / Sales 2026 * |
3.16x | EV / Sales 2027 * | 3.12x |
| Free-Float |
69.82% | Yield 2026 * |
4.01% | Yield 2027 * | 4.08% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BMY | Delayed | |
CBOE
| BMY | Real-time | |
|
Xetra
| BRM | Delayed | |
|
London S.E.
| 0R1F | Delayed | |
|
Boerse Muenchen
| BRM | Real-time | |
|
Tradegate
| BRM | Real-time | |
|
Börse Stuttgart
| BRM | Delayed | |
|
CBOE
| 0R1F | Real-time | |
|
Mexican S.E.
| BMY * | End-of-day quote | |
|
Deutsche Boerse AG
| BRM | Delayed | |
|
Swiss Exchange
| BMY | Delayed | |
|
Swiss Exchange
| BMY | Delayed | |
|
Wiener Boerse
| BMYS | End-of-day quote | |
|
Lima
| BMYUS | End-of-day quote | |
|
Borsa Italiana
| 1BMY | End-of-day quote | |
|
CBOE
| Real-time |
Last Transcript: Bristol-Myers Squibb Company
| 1 week | -4.07% | ||
| Current month | -4.73% | ||
| 1 month | -0.82% | ||
| 3 months | +13.98% | ||
| 6 months | +20.81% | ||
| Current year | +19.01% |
| 1 week | 64.1 |  | 66.82 |
| 1 month | 64.1 | | 67.28 |
| Current year | 52.02 | | 67.28 |
| 1 year | 43.5 | | 67.28 |
| 3 years | 40.1 | | 72.7 |
| 5 years | 40.1 | | 72.7 |
| 10 years | 40.1 | | 72.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2023-10-31 | |
David Elkins
DFI | Director of Finance/CFO | 58 | 2019-11-19 |
| Chief Tech/Sci/R&D Officer | 57 | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 2024-03-31 | |
Peter Arduini
BRD | Director/Board Member | 61 | 2016-03-31 |
Theodore Samuels
BRD | Director/Board Member | 71 | 2017-02-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -4.07% | - | - | 128B | |
| +0.04% | +3.34% | +51.12% | +101.82% | 1,027B | |
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | |
| -0.02% | +2.66% | +18.91% | +71.47% | 467B | |
| -1.22% | +3.66% | +36.44% | +38.32% | 350B | |
| -0.79% | +2.73% | +19.03% | +25.08% | 268B | |
| +0.58% | +6.76% | +11.13% | +16.52% | 257B | |
| +1.55% | +2.20% | +39.81% | +46.55% | 205B | |
| +0.79% | +1.84% | -28.27% | -56.71% | 190B | |
| -0.52% | +4.45% | +32.12% | +98.51% | 187B | |
| Average | +0.18% | +2.96% | +26.15% | +45.30% | 400.23B | |
| Weighted average by Cap. | +0.22% | +3.01% | +35.17% | +61.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 49.84B 43.46B 41.04B 37.27B 69.82B 4,783B 70.11B 492B 190B 2,432B 187B 183B 7,824B | 48.21B 42.04B 39.69B 36.04B 67.53B 4,626B 67.81B 475B 183B 2,352B 181B 177B 7,567B |
| Net income | 11.18B 9.75B 9.2B 8.36B 15.66B 1,072B 15.72B 110B 42.54B 545B 41.98B 41.05B 1,754B | 10.52B 9.17B 8.66B 7.86B 14.73B 1,009B 14.79B 104B 40.03B 513B 39.51B 38.63B 1,651B |
| Net Debt | 28.74B 25.06B 23.66B 21.49B 40.26B 2,757B 40.42B 283B 109B 1,402B 108B 106B 4,511B | 21.77B 18.99B 17.93B 16.28B 30.5B 2,089B 30.63B 215B 82.87B 1,062B 81.79B 79.97B 3,418B |
| Date | Price | Change |
|---|---|---|
| 26-09-17 | US$64.10 | 0.00% |
| 26-09-16 | US$64.10 | 0.00% |
| 26-09-15 | US$64.10 | -4.07% |
| 26-09-14 | US$66.82 | 0.00% |
| 26-09-11 | US$66.82 | 0.00% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BMY Stock
- BMYUS Stock
Select your edition
All financial news and data tailored to specific country editions
